Clinical Trials Logo

Clinical Trial Summary

RESSURE-NIRS registry is designed to investigate clinical and pathophysiological characteristics of NIRS-derived lipid-rich plaque in patients with coronary artery disease. This is an on-going multi-center prospective registry in Japan.


Clinical Trial Description

NIRS imaging is an invasive intravascular imaging modality to quantitatively visualize lipid-rich atheroma in vivo. While NIRS-derived lipid-rich plaque has been shown to associate with cardiovascular events, there is limited clinical data about the association of this high-risk plaque with risk factors, medication use, prognosis and response of PCI. RESSURE-NIRS registry is an on-going multi-center prospective registry in Japan, which enroll subjects with coronary artery disease who received NIRS imaging to evaluate coronary atherosclerosis. The primary outcome is maximum 4-mm lipid core burden index at coronary lesions measured by NIRS imaging. Secondary major outcomes include entire lipid core burden index, plaque volume, plaque attenuation and echo-lucent area. The anticipated number of study subjects is 2000 cases. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04864171
Study type Observational [Patient Registry]
Source National Cerebral and Cardiovascular Center
Contact Yu Kataoka, MD
Phone +81661701070
Email [email protected]
Status Recruiting
Phase
Start date October 9, 2018
Completion date March 31, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT04460482 - Near-infrared Spectroscopy Guided Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction N/A